AlphaQuest LLC Has $111,000 Position in Danaher Corporation $DHR

AlphaQuest LLC cut its stake in shares of Danaher Corporation (NYSE:DHR) by 91.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 562 shares of the conglomerate’s stock after selling 5,868 shares during the quarter. AlphaQuest LLC’s holdings in Danaher were worth $111,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. MGO One Seven LLC increased its holdings in Danaher by 485.7% during the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after purchasing an additional 20,813 shares in the last quarter. Chicago Capital LLC raised its stake in shares of Danaher by 11.6% in the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock worth $2,634,000 after purchasing an additional 1,391 shares during the last quarter. UniSuper Management Pty Ltd raised its stake in shares of Danaher by 1.6% in the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after purchasing an additional 2,667 shares during the last quarter. Asahi Life Asset Management CO. LTD. purchased a new stake in shares of Danaher in the first quarter worth approximately $539,000. Finally, ASR Vermogensbeheer N.V. raised its stake in shares of Danaher by 1.9% in the second quarter. ASR Vermogensbeheer N.V. now owns 322,924 shares of the conglomerate’s stock worth $63,787,000 after purchasing an additional 6,136 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 11.10% of the company’s stock.

Danaher Price Performance

Danaher stock opened at $213.89 on Wednesday. The business’s 50 day simple moving average is $203.68 and its 200 day simple moving average is $199.98. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $258.23. The company has a market cap of $151.08 billion, a price-to-earnings ratio of 44.10, a PEG ratio of 3.28 and a beta of 0.77. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. During the same period in the prior year, the company earned $1.71 earnings per share. Danaher’s revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Friday, September 26th. Danaher’s dividend payout ratio is 26.39%.

Analyst Upgrades and Downgrades

DHR has been the subject of several analyst reports. Royal Bank Of Canada set a $241.00 price objective on Danaher in a research note on Tuesday, September 2nd. TD Cowen increased their price objective on Danaher from $250.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft upped their target price on Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Bank of America reduced their target price on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a report on Monday, September 22nd. Finally, Robert W. Baird set a $247.00 target price on Danaher in a report on Wednesday, October 22nd. Eighteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $243.39.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.